Literature DB >> 28748285

Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study.

Noémie Coron1,2, Marc Pihet1, Emilie Fréalle3, Yolande Lemeille4, Claudine Pinel4, Hervé Pelloux4, Gilles Gargala5, Loic Favennec5, Isabelle Accoceberry6, Isabelle Durand-Joly7, Frédéric Dalle8, Frédéric Huet9, Annlyse Fanton9, Amale Boldron10, Guy-André Loeuille10, Philippe Domblides11, Bérengère Coltey12, Isabelle Pin13, Catherine Llerena13, Françoise Troussier14, Christine Person14, Christophe Marguet15, Nathalie Wizla16, Caroline Thumerelle16, Dominique Turck16, Stéphanie Bui17, Michael Fayon17, Alain Duhamel18, Anne Prévotat19, Benoit Wallaert19, Sylvie Leroy19,20, Jean-Philippe Bouchara1, Laurence Delhaes21,22.   

Abstract

Fungal respiratory colonization of cystic fibrosis (CF) patients emerges as a new concern; however, the heterogeneity of mycological protocols limits investigations. We first aimed at setting up an efficient standardized protocol for mycological analysis of CF sputa that was assessed during a prospective, multicenter study: "MucoFong" program (PHRC-06/1902). Sputa from 243 CF patients from seven centers in France were collected over a 15-month period and submitted to a standardized protocol based on 6 semi-selective media. After mucolytic pretreatment, sputa were plated in parallel on cycloheximide-enriched (ACT37), erythritol-enriched (ERY37), benomyl dichloran-rose bengal (BENO37) and chromogenic (CAN37) media incubated at 37 °C and on Sabouraud-chloramphenicol (SAB27) and erythritol-enriched (ERY27) media incubated at 20-27 °C. Each plate was checked twice a week during 3 weeks. Fungi were conventionally identified; time for detection of fungal growth was noted for each species. Fungal prevalences and media performances were assessed; an optimal combination of media was determined using the Chi-squared automatic interaction detector method. At least one fungal species was isolated from 81% of sputa. Candida albicans was the most prevalent species (58.8%), followed by Aspergillus fumigatus (35.4%). Cultivation on CAN37, SAB27, ACT37 and ERY27 during 16 days provided an optimal combination, detecting C. albicans, A. fumigatus, Scedosporium apiospermum complex and Exophiala spp. with sensitivities of 96.5, 98.8, 100 and 100%. Combination of these four culture media is recommended to ensure the growth of key fungal pathogens in CF respiratory specimens. The use of such consensual protocol is of major interest for merging results from future epidemiological studies.

Entities:  

Keywords:  Aspergillus; Cystic fibrosis; Filamentous fungi; Lung mycobiota; Molds; Mycological examination

Mesh:

Year:  2017        PMID: 28748285     DOI: 10.1007/s11046-017-0173-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  51 in total

1.  Sputum Candida albicans presages FEV₁ decline and hospital-treated exacerbations in cystic fibrosis.

Authors:  Sanjay H Chotirmall; Elaine O'Donoghue; Kathleen Bennett; Cedric Gunaratnam; Shane J O'Neill; Noel G McElvaney
Journal:  Chest       Date:  2010-05-14       Impact factor: 9.410

Review 2.  Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist.

Authors:  Josep Guarro; A Serda Kantarcioglu; Regine Horré; Juan Luis Rodriguez-Tudela; Manuel Cuenca Estrella; Juan Berenguer; G Sybren de Hoog
Journal:  Med Mycol       Date:  2006-06       Impact factor: 4.076

Review 3.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

Review 4.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.

Authors:  Françoise Symoens; Christiane Knoop; Marc Schrooyen; Olivier Denis; Marc Estenne; Nicole Nolard; Frédérique Jacobs
Journal:  J Heart Lung Transplant       Date:  2006-03-23       Impact factor: 10.247

6.  Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France.

Authors:  André Paugam; Marie-Thérèse Baixench; Nadine Demazes-Dufeu; Pierre-Régis Burgel; Elise Sauter; Reem Kanaan; Daniel Dusser; Jean Dupouy-Camet; Dominique Hubert
Journal:  Med Mycol       Date:  2010-11       Impact factor: 4.076

7.  Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi.

Authors:  Andrew M Borman; Michael D Palmer; Laurence Delhaes; Jacqueline Carrère; Loïc Favennec; Stéphane Ranque; Jean-Pierre Gangneux; Regine Horré; Jean-Philippe Bouchara
Journal:  Med Mycol       Date:  2010-11       Impact factor: 4.076

8.  Development of IgG antibodies to Exophiala dermatitidis is associated with inflammatory responses in patients with cystic fibrosis.

Authors:  Nahid Kondori; Anders Lindblad; Christina Welinder-Olsson; Christine Wennerås; Marita Gilljam
Journal:  J Cyst Fibros       Date:  2014-01-14       Impact factor: 5.482

9.  Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF).

Authors:  Yuriko Nagano; B Cherie Millar; Colin E Goldsmith; James M Walker; J Stuart Elborn; Jackie Rendall; John E Moore
Journal:  J Cyst Fibros       Date:  2008-08-23       Impact factor: 5.482

10.  Decision tree methods: applications for classification and prediction.

Authors:  Yan-Yan Song; Ying Lu
Journal:  Shanghai Arch Psychiatry       Date:  2015-04-25
View more
  13 in total

1.  Fungal Respiratory Infections in Cystic Fibrosis (CF): Recent Progress and Future Research Agenda.

Authors:  Jean-Philippe Bouchara; Françoise Symoens; Carsten Schwarz; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2018-02       Impact factor: 2.574

2.  Laboratory Diagnosis and Characterization of Fungal Disease in Patients with Cystic Fibrosis (CF): A Survey of Current UK Practice in a Cohort of Clinical Microbiology Laboratories.

Authors:  Maeve Boyle; John E Moore; Joanna L Whitehouse; Diana Bilton; Damian G Downey
Journal:  Mycopathologia       Date:  2018-03-02       Impact factor: 2.574

3.  Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis.

Authors:  Gina Hong; Kevin J Psoter; Mark T Jennings; Christian A Merlo; Michael P Boyle; Denis Hadjiliadis; Steven M Kawut; Noah Lechtzin
Journal:  J Cyst Fibros       Date:  2018-02-12       Impact factor: 5.482

4.  Exophiala dermatitidis Revealing Cystic Fibrosis in Adult Patients with Chronic Pulmonary Disease.

Authors:  Frédéric Grenouillet; Bernard Cimon; Heloise Pana-Katatali; Christine Person; Marie Gainet-Brun; Marie-Claire Malinge; Yohann Le Govic; Bénédicte Richaud-Thiriez; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2017-11-01       Impact factor: 2.574

5.  Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis.

Authors:  Gina Hong; Noah Lechtzin; Denis Hadjiliadis; Steven M Kawut
Journal:  Pediatr Pulmonol       Date:  2018-12-14

Review 6.  Emerging Fungal Threats in Cystic Fibrosis.

Authors:  C Schwarz; P Eschenhagen; J P Bouchara
Journal:  Mycopathologia       Date:  2021-07-28       Impact factor: 2.574

7.  Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis.

Authors:  Perrine Soret; Louise-Eva Vandenborght; Florence Francis; Noémie Coron; Raphael Enaud; Marta Avalos; Thierry Schaeverbeke; Patrick Berger; Michael Fayon; Rodolphe Thiebaut; Laurence Delhaes
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

Review 8.  Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation.

Authors:  Sabine Renner; Edith Nachbaur; Peter Jaksch; Eleonora Dehlink
Journal:  J Fungi (Basel)       Date:  2020-12-21

Review 9.  Fungal Infection and Inflammation in Cystic Fibrosis.

Authors:  T Spencer Poore; Gina Hong; Edith T Zemanick
Journal:  Pathogens       Date:  2021-05-18

Review 10.  The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges.

Authors:  Pei Yee Tiew; Micheál Mac Aogain; Nur A'tikah Binte Mohamed Ali; Kai Xian Thng; Karlyn Goh; Kenny J X Lau; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2020-01-01       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.